Navigation Links
Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
Date:4/16/2009

CLEVELAND, Ohio, April 16 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products.

Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson.

Johnson & Johnson LLC will have exclusive rights to distribute Simbionix's line of advanced medical simulators in hospitals in the Russia and CIS countries.

"We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into the Russian republic' hospitals, teaching facilities and interventional clinics," said Simbionix CEO Gary Zamler. "This agreement ushers in a new era of simulation-based training for Russia's medical community and we envision beneficial for the countries covered by the agreement, Johnson & Johnson LLC,and Simbionix."

"In the last year, Simbionix has increased its distribution channels and its exposure to the international market, "explains Mr. Doron Zilberman, Simbionix's VP of International Sales. "We see Russia as one of the leading markets in the emerging medical world; this agreement is an additional step of our on going success in the international market ..."

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit

SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
2. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
3. Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
4. Premier Research Announces Milestone Investigational New Drug Application
5. PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
6. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
9. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
10. Schering-Plough Announces Results of the Early ACS Trial
11. Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014   MedeAnalytics ... solution that brings complete visibility to a provider,s ... an ever-evolving reimbursement landscape. Powered by the industry,s ... to the critical point between patient access and ... The solution will improve revenue capture, minimize audit ...
(Date:9/17/2014)... , Sept. 17, 2014  The law ... today announced that it will serve as host ... and Avoiding the Risks of Healthcare Reform," a ... will examine delivery systems, reimbursement, compliance and enforcement ... Act. Logo -  http://photos.prnewswire.com/prnh/20140916/146606 ...
(Date:9/17/2014)... , Sept. 17, 2014 Cardiac Dimensions ... data from the TITAN II clinical trial of ... and sustained improvements in mitral regurgitation, functional improvement, ... long-term safety and efficacy data, which was consistent ... Sept. 13 at the 26 th annual ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... today announced that BioSpecifics, President, Tom Wegman, will present ... Conference on Friday, October 22, 2010 at 3:00 pm ... New York. A live webcast of ...
... Network, already the largest distributor of FDA-approved drug ... that this month it will surpass six million ... ("REMS") program alerts delivered to prescribers. FDA-approved Drug-Alerts ... Network,s Health Care Notification Network (HCNN) service since ...
Cached Medicine Technology:PDR Network Delivers Six Million Drug Alerts & REMS 2PDR Network Delivers Six Million Drug Alerts & REMS 3
(Date:9/17/2014)... Phoenix, Arizona (PRWEB) September 17, 2014 ... valuable option for children who cannot live with their ... is necessary to continue to enhance services and supports ... League of America’s (CWLA) National Kinship Care Conference is ... field’s collective knowledge of best practice, policy, program and ...
(Date:9/17/2014)... City, UT (PRWEB) September 17, 2014 ... America 2015 Kira Kazantsev and ushered in a ... charitable support. As Miss America Organization’s official national ... welcoming Kazantsev as its newest National Goodwill Ambassador. ... at member Children’s Miracle Network Hospitals across the ...
(Date:9/17/2014)... spaceflight has been reserved for the very healthy. ... the highest physical and psychological standards to prepare ... advent of commercial spaceflight, average people can now ... had very little information about what medical conditions ... the spaceflight environment, as most medical conditions have ...
(Date:9/17/2014)... research study was announced today that will analyze ... long-term wellness and contribute to healthy aging. ... and funded through a $10 million unrestricted gift ... WELL aims to identify lifestyle and environmental factors ... wellness as they age. WELL will be designed, ...
(Date:9/17/2014)... struggle to distinguish between a business strategy and business plan, ... answer by reading Per Wickstrom’s latest blog post. , “The ... and a business strategy are both strategic – and what’s ... view it is that a business plan is part one, ... , According to the blog post, a business plan is ...
Breaking Medicine News(10 mins):Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 3Health News:Space: The final frontier… open to the public 2Health News:First-ever research study examines impacts of diet and lifestyle on healthy aging 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2
... Huntington,s disease may give patients hope for a cure. ... tissue of Huntington,s disease patients determined that an overactive ... cells to die. Toning down the activity of that ... kept those cells alive, according to the research team ...
... medical literature on cannabis use and sexual health has ... performance. "Cannabis is the most widely-used illicit drug ... Department of Pharmacology and Toxicology. "It is also often ... of the hazardous effects it may be having on ...
... the brain may need a new name, say scientists who ... finding, published in PLoS One , may help explain ... of surviving it, according to scientists at Georgia Health Sciences ... off a building or just the thought of either ...
... Jerusalem, February 22, 2011 -- The portion of the brain ... to a new study by researchers from the Hebrew University ... blind people as they read words in Braille show activity ... up when sighted readers read. The findings challenge the textbook ...
... consecutive year, Women & Infants Hospital of Rhode Island ... Care by the Clinical Sciences Institute of OptumHealth, an ... health care providers are created equal. For complex ... a rigorous evaluation process, OptumHealth developed Centers of Excellence ...
... herald the onset of major depression and the associated ... Research that focuses on access to treatment for adolescents ... persistent disparities based on race and ethnicity. Unfortunately such ... across all individuals and communities has yet to be ...
Cached Medicine News:Health News:Huntington's disease breakthrough equals hope for patients 2Health News:Brain's 'reward' center also responds to bad experiences 2Health News:Brain doesn't need vision at all in order to 'read' material 2Health News:Brain doesn't need vision at all in order to 'read' material 3Health News:Women & Infants named Center of Excellence for Neonatal Care for fifth year 2Health News:Racial and ethnic minority adolescents less likely to receive treatment for major depression 2
5 mm tying platform. Round knurled handle with dull finish. Curved shafts. Overall length 3.9 inches....
Straight shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches....
Curved shafts with 12 mm tying platform. Serrated handle with polished finish. Overall length 4.3 inches....
Hartman Mosquito forceps, straight, 3-1/2", German stainless steel...
Medicine Products: